Chapter 1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

Chapter 2. Research Methodology

2.1. Qualitative Research

2.1.1. Primary & Secondary Sources

2.2. Quantitative Research

2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Chapter 3. Executive Summary: Japan Bioanalytical Testing Service Market

Chapter 4. Japan Bioanalytical Testing Service Market Overview

4.1. Industry Value Chain Analysis

4.1.1. Sample Collection

4.1.2. Sample Preparation & Validation

4.1.3. Service Provider

4.1.4. End User

4.2. Industry Outlook

4.2.1. Advancement in bioanalytical Techniques for Biotherapeutics

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis

4.4.1. Bargaining Power of Suppliers

4.4.2. Bargaining Power of Buyers

4.4.3. Threat of Substitutes

4.4.4. Threat of New Entrants

4.4.5. Degree of Competition

4.5. Market Dynamics and Trends

4.5.1. Growth Drivers

4.5.2. Restraints

4.5.3. Challenges

4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook

4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030

4.7.2. Price Trend Analysis, By Type Test

4.8. Competition Dashboard

4.8.1. Market Concentration Rate

4.8.2. Company Market Share Analysis (Value %), 2020

4.8.3. Competitor Mapping

Chapter 5. Bioanalytical Testing Service Market Analysis, By Test Type

5.1. Key Insights

5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

5.2.1. Cell-based Assays

5.2.1.1. Bacterial cell-based assays

5.2.1.2. Viral cell-based assays

5.2.2. Virology Testing

5.2.2.1. In Vitro Virology Testing

5.2.2.2. In Vivo Virology Testing

5.2.3. Species-specific Viral PCR Assays

5.2.4. Method Development Optimization and Validation

5.2.5. Serology, Immunogenicity, and Neutralizing Antibodies

5.2.6. Biomarker Assays

5.2.6.1. LBA/LC-MS/MS

5.2.7. Pharmacokinetic Testing

5.2.8. Others

Chapter 6. Bioanalytical Testing Service Market Analysis, By Molecule Type

6.1. Key Insights

6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

6.2.1. Small Molecule Bioanalysis

6.2.2. Large Molecule Bioanalysis

6.2.3. Others

Chapter 7. Bioanalytical Testing Service Market Analysis, By Application

7.1. Key Insights

7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

7.2.1. Oncology

7.2.2. Neurology

7.2.3. Infectious Diseases

7.2.4. Gastroenterology

7.2.5. Cardiology

7.2.6. Others

Chapter 8. Bioanalytical Testing Service Market Analysis, By End User

8.1. Key Insights

8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

8.2.1. Pharma & Biotechnology Companies

8.2.2. Contract Research Organizations

8.2.3. Others

Chapter 9. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

9.1. Medpace

9.2. PRA HEALTH SCIENCES (Takeda)

9.3. Eurofins Scientific

9.4. ICON plc

9.5. Intertek Group

9.6. inVentiv Health

9.7. IQVIA

9.8. Laboratory Corporation of America

9.9. Medpace

9.10. PPD, Inc.

9.11. Charles River Laboratories International, Inc.

9.12. SGS SA

9.13. Syneos Health

9.14. WuXi AppTec

9.15. Other Prominent Players